High sensitive troponin T as a new biomarker for atrial fibrillation development after cardiac surgery

Kinetics of high sensitive troponin T (HSTNT) after cardiac surgery

Introduction Perioperative myocardial infarction (PMI) in the setting of cardiac surgery represent a considerable risk to patients with significant mortality and morbidity. The role of highly sensitive cardiac troponin T (hsTnT) has not been evaluated in the setting of cardiac surgery, instead Cardiac Troponin T (TnT) and Creatine Kinase MB (CK-MB) are commonly used for the diagnosis of PMI [1].

High-sensitive cardiac troponin T

Cardiac troponin is the preferred biomarker for the diagnosis of acute myocardial infarction (AMI). The recent development of a high-sensitive cardiac troponin T (hs-cTnT) assay permits detection of very low levels of cTnT. Using the hs-cTnT assay improves the overall diagnostic accuracy in patients with suspected AMI, while a negative result also has a high negative predictive value. The gain ...

Kinetics of Highly Sensitive Troponin T after Cardiac Surgery

Perioperative myocardial infarction (PMI) confers a considerable risk in cardiac surgery settings; finding the ideal biomarker seems to be an ideal goal. Our aim was to assess the diagnostic accuracy of highly sensitive troponin T (hsTnT) in cardiac surgery settings and to define a diagnostic level for PMI diagnosis. This was a single-center prospective observational study analyzing data from a...

Atrial fibrillation after cardiac surgery.

trial fibrillation (AF) after cardiac surgery is a major cause of morbidity and mortality, and it has been reported that the rate of occurrence is 18–40%.1–5 Various causes have been studied, including advanced age, body mass index, obesity, left atrial dimensions, cardiac dysfunction, chronic respiratory failure, renal dysfunction, fluid balance, preoperative medications, inflammation, and fib...

Atrial fibrillation after cardiac surgery